Title:
アゼチジン誘導体、その調製方法、及びその使用
Document Type and Number:
Japanese Patent JP6860267
Kind Code:
B2
Abstract:
The present invention relates to an azetidine derivative for use as a Janus kinase (JAK) inhibitor, a drug composition comprising same, a preparation method therefor, and a use thereof in the treatment of JAK-related diseases comprising, for example, inflammatory diseases, autoimmune diseases, and cancers.
Inventors:
Che, Inon
Yu, Zejin
Den, Ji Wen
Joo, Jun
One, Ao
Fen, Yen
London
Zen
Song, Hun Mei
Ye, Jijoon
Chi, way
Sue Dong Hai
Wan, rechung
One, Jiny
Yu, Zejin
Den, Ji Wen
Joo, Jun
One, Ao
Fen, Yen
London
Zen
Song, Hun Mei
Ye, Jijoon
Chi, way
Sue Dong Hai
Wan, rechung
One, Jiny
Application Number:
JP2018518690A
Publication Date:
April 14, 2021
Filing Date:
December 08, 2016
Export Citation:
Assignee:
Sichuan Cologne-Biotech By Offer Matheutical Company Limited
International Classes:
C07D471/04; A61K31/365; A61K31/437; A61K39/395; A61P19/02; A61P29/00; A61P35/00; A61P37/06; A61P43/00
Domestic Patent References:
| JP2011514909A | ||||
| JP2012504639A | ||||
| JP2013522214A | ||||
| JP2014520146A |
Foreign References:
| WO2013173506A2 |
Attorney, Agent or Firm:
Ikeda adult
Junichiro Sakamaki
Masakazu Noda
Junichiro Sakamaki
Masakazu Noda